Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FHQLP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,739
Award facts
- Contract value 100% obligated
- $11,738.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,738.53 to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (180-count supply) with a firm fixed price structure. This non-set-aside award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Entresto is a combination medication used to treat heart failure, representing the type of critical pharmaceutical product essential to military and veteran healthcare systems supported by the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements through competitive award processes, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FHQLP?
SPE2DB25FHQLP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FHQLP worth?
The government has obligated $11,739 on SPE2DB25FHQLP.
Is contract SPE2DB25FHQLP an order under another contract?
Yes. SPE2DB25FHQLP is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB25FHQLP competed?
The extent of competition for SPE2DB25FHQLP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award